Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced that it has initiated shipments of terconazole in a 3-day cream.

Terconazole vaginal cream 0.8 per cent is the equivalent of Terazol 3 (terconazole) vaginal cream 0.8 per cent, and is indicated for the local treatment of vulvovaginal candidiasis.

For the 12-months ending February 2004, Terazol 3 vaginal cream 0.8 per cent had sales of approximately $27.7 million, according to IMS Health data.